President Jair Bolsonaro (PL) spoke this Sunday (Jan 16) about the request for the release of covid-19 self-tests sent to the National Health Surveillance Agency (Anvisa) by the Ministry of Health. National Testing Expansion Plan”.
“Information on the antigen self-test for the detection of covid-19 was forwarded to Anvisa. The use of the self-test can guarantee the quickest start of actions to interrupt the transmission chain”, he wrote on social media.
Bolsonaro added that “the objective is for the tests to be made available in pharmacy/drugstore chains and other health establishments for people with or without symptoms who are interested in carrying out self-testing”.
– National Testing Expansion Plan:
– Forwarded to Anvisa information about the antigen self-test for the detection of Covid19.
– Using the self-test can ensure faster initiation of actions to break the transmission chain.
— Jair M. Bolsonaro (@jairbolsonaro) January 16, 2022
– Antigen tests are already widely used in UPS and Family Clinics or Basic Health Units throughout the country.
– There are already more than 381 million doses of vaccine distributed by the @govbr to all states and municipalities in Brazil.@minsaude
— Jair M. Bolsonaro (@jairbolsonaro) January 16, 2022
The request for release of self-tests was sent to Anvisa on Thursday (13.Jan). Among the justifications presented by the folder are the possibility of providing the test to people who have symptoms of covid, as well as asymptomatic and third parties who have had contact. In addition to the possibility of carrying out the test outside and closed environments and in contact with other people.
The ministry also indicates that the measure can reduce the burden on health services, by reducing attendance and improving assistance for people who test positive for the coronavirus.
Faced with the increase in cases of covid-19 and other diseases with flu-like symptoms, there was an explosion of searches for tests. The demand has been such that the Brazilian Association of Diagnostic Medicine (Abramed) warned of the risk of shortages and recommended priority for the use of the exam in critically ill patients.
President Jair Bolsonaro (PL) spoke this Sunday (Jan 16) about the request for the release of covid-19 self-tests sent to the National Health Surveillance Agency (Anvisa) by the Ministry of Health. National Testing Expansion Plan”.
“Information on the antigen self-test for the detection of covid-19 was forwarded to Anvisa. The use of the self-test can guarantee the quickest start of actions to interrupt the transmission chain”, he wrote on social media.
Bolsonaro added that “the objective is for the tests to be made available in pharmacy/drugstore chains and other health establishments for people with or without symptoms who are interested in carrying out self-testing”.
– National Testing Expansion Plan:
– Forwarded to Anvisa information about the antigen self-test for the detection of Covid19.
– Using the self-test can ensure faster initiation of actions to break the transmission chain.
— Jair M. Bolsonaro (@jairbolsonaro) January 16, 2022
– Antigen tests are already widely used in UPS and Family Clinics or Basic Health Units throughout the country.
– There are already more than 381 million doses of vaccine distributed by the @govbr to all states and municipalities in Brazil.@minsaude
— Jair M. Bolsonaro (@jairbolsonaro) January 16, 2022
The request for release of self-tests was sent to Anvisa on Thursday (13.Jan). Among the justifications presented by the folder are the possibility of providing the test to people who have symptoms of covid, as well as asymptomatic and third parties who have had contact. In addition to the possibility of carrying out the test outside and closed environments and in contact with other people.
The ministry also indicates that the measure can reduce the burden on health services, by reducing attendance and improving assistance for people who test positive for the coronavirus.
Faced with the increase in cases of covid-19 and other diseases with flu-like symptoms, there was an explosion of searches for tests. The demand has been such that the Brazilian Association of Diagnostic Medicine (Abramed) warned of the risk of shortages and recommended priority for the use of the exam in critically ill patients.
